Taurine red bull or red herring?

Hypertension

Volumn 53, Issue 6, 2009, Pages 909-911

  Wesseling, Sebastiaan ^a   Koeners, Maarten P ^a   Joles, Jaap A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; BILE ACID; CCAAT ENHANCER BINDING PROTEIN; CHOLESTEROL; CYSTEINE; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN; METHIONINE; TAURINE; TRANSFER RNA; URSODEOXYCHOLIC ACID;

ANTIHYPERTENSIVE ACTIVITY; APOPTOSIS; BIOSYNTHESIS; CELL STRESS; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CORONARY ARTERY ATHEROSCLEROSIS; DIETARY INTAKE; DIZZINESS; DRUG EFFECT; EDITORIAL; ENDOPLASMIC RETICULUM; HAMSTER; HEART MUSCLE FIBROSIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERTENSION; KIDNEY FUNCTION; NEGATIVE FEEDBACK; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSMOREGULATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN MALNUTRITION; RABBIT; VASCULAR SMOOTH MUSCLE; CORONARY ARTERY DISEASE; DIET SUPPLEMENTATION; METABOLISM; NOTE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

CORONARY ARTERY DISEASE; DIETARY SUPPLEMENTS; HUMANS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TAURINE;

EID: 67049172125     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.130427     Document Type: Editorial

References (22)

1. Bouckenooghe T, Remacle C, Reusens B. Is taurine a functional nutrient? Curr Opin Clin Nutr Metab Care. 2006;9:728-733.
2. Brosnan JT, Brosnan ME. The sulfur-containing amino acids: an overview. J Nutr. 2006;136:1636S-1640S.
3. Li X, Bazer FW, Gao H, Jobgen W, Johnson GA, Li P, McKnight JR, Satterfield MC, Spencer TE, Wu G. Amino acids and gaseous signaling. Amino Acids. In press.
4. Wang BY, Singer AH, Tsao PS, Drexler H, Kosek J, Cooke JP. Dietary arginine prevents atherogenesis in the coronary artery of the hypercho-lesterolemic rabbit. J Am Coll Cardiol. 1994;23:452-458.
5. Palinski W, Napoli C. The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis. FASEB J. 2002;16:1348-1360.
6. Zulli A, Hare DL, Buxton BF, Black MJ. High dietary methionine plus cholesterol exacerbates atherosclerosis formation in the left main coronary artery of rabbits. Atherosclerosis. 2004;176:83-89.
7. Zulli A, Hare DL, Buxton BF, Black MJ. The combination of high dietary methionine plus cholesterol induces myocardial fibrosis in rabbits. Atherosclerosis. 2006;185:278-281.
8. Zulli A, Lau E, Wijaya BPP, Jin X, Sutarga K, Schwartz GD, Learmont J, Wookey PJ, Zinello A, Carru C, Hare DL. High dietary taurine reduces apoptosis and atherosclerosis in the left main coronary artery. Association with reduced CCAAT/enhancer binding protein homologous protein and total plasma homocysteine but not lipidemia. Hypertension. 2009;53: 1017-1022.
9. Martin-Venegas R, Rodriguez-Lagunas MJ, Mercier Y, Geraert PA, Ferrer R. Effect of pH on L- and D-methionine uptake across the apical membrane of Caco-2 cells. Am J Physiol Cell Physiol. 2009;296: C632-C638.
10. Chang L, Xu J, Yu F, Zhao J, Tang X, Tang C. Taurine protected myocardial mitochondria injury induced by hyperhomocysteinemia in rats. Amino Acids. 2004;27:37-48.
11. Yalcinkaya S, Unlucerci Y, Giris M, Olgac V, Dogru-Abbasoglu S, Uysal M. Oxidative and nitrosative stress and apoptosis in the liver of rats fed on high methionine diet: protective effect of taurine. Nutrition. 2009;25: 436-444.
12. Schaffer SW, Azuma J, Mozaffari M. Role of antioxidant activity of taurine in diabetes. Can J Physiol Pharmacol. 2009;87:91-99.
13. Nonaka H, Tsujino T, Watari Y, Emoto N, Yokoyama M. Taurine prevents the decrease in expression and secretion of extracellular superoxide dis-mutase induced by homocysteine: amelioration of homocysteine-induced endoplasmic reticulum stress by taurine. Circulation. 2001;104:1165-1170.
14. Ozcan U, Yilmaz E, Ozcan L, Furuhashi M, Vaillancourt E, Smith RO, Gorgun CZ, Hotamisligil GS. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science. 2006;313:1137-1140.
15. Bellentani S, Pecorari M, Cordoma P, Marchegiano P, Manenti F, Bosisio E, De Fabiani E, Galli G. Taurine increases bile acid pool size and reduces bile saturation index in the hamster. J Lipid Res. 1987;28: 1021-1027.
16. Yamori Y, Murakami S, Ikeda K, Nara Y. Fish and lifestyle-related disease prevention: experimental and epidemiological evidence for anti-atherogenic potential of taurine. Clin Exp Pharmacol Physiol. 2004; 31(suppl 2):S20-S23.
17. Nakanishi T, Otaki Y, Hasuike Y, Nanami M, Itahana R, Miyagawa K, Nishikage H, Izumi M, Takamitsu Y. Association of hyperhomocysteinemia with plasma sulfate and urine sulfate excretion in patients with progressive renal disease. Am J Kidney Dis. 2002;40:909-915.
18. Suliman ME, Barany P, Filho JC, Lindholm B, Bergstrom J. Accumulation of taurine in patients with renal failure. Nephrol Dial Transplant. 2002;17:528-529.
19. Remade C, Dumortier O, Bol V, Goosse K, Romanus P, Theys N, Bouckenooghe T, Reusens B. Intrauterine programming of the endocrine pancreas. Diabetes Obes Metab. 2007;9(suppl 2): 196-209.
20. Wesseling S, Koeners MP, Kantouh F, Joles JA, Braam B. Consequences of perinatal treatment with L-arginine and antioxidants for the renal transcriptome in spontaneously hypertensive rats. Pflugers Arch. In press.
21. Shekelle PG, Morton SC, Jungvig LK, Udani J, Spar M, Tu W, M JS, Coulter I, Newberry SJ, Hardy M. Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease. J Gen Intern Med. 2004; 19:380-389.
22. Bazzano LA, Reynolds K, Holder KN, He J. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA. 2006;296:2720-2726.